RAFLF Stock Raffles Medical Group (RAFLF, $0.81) was a top quarterly gainer, rising +34.55%

GET DAILY SIGNALS

Get AI intraday signals

RAFLF - Raffles Medical Group Ltd.

Loading...

Price: $0.8073

Daily change: +$0.0573 (+7.64%)

Daily volume: 759

3-month price change: +$0.2073 (+34.55%)

Capitalization: $1.5B

Industry: Medical/Nursing Services

RAFLF sees its Stochastic Oscillator recovers from oversold territory

On July 25, 2025, the Stochastic Oscillator for RAFLF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 19 instances where the indicator left the oversold zone. In of the 19 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Technical Analysis (Indicators)

Bullish Trend Analysis

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for RAFLF turned negative on July 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RAFLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (4.275). P/E Ratio (17.544) is within average values for comparable stocks, (74.174). RAFLF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). Dividend Yield (0.028) settles around the average of (0.025) among similar stocks. P/S Ratio (3.464) is also within normal values, averaging (9.167).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RAFLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.